Nobuki Shioya, N. Inoue, Hiroki Sato
Jul 1, 2022
Citations
0
Influential Citations
2
Citations
Quality indicators
Journal
Clinical Case Reports
Abstract
Dialysis‐related adverse reactions can be serious and difficult to predict. In our case, nafamostat mesylate (NM) was thought to be the cause of cardiopulmonary arrest (CPA) due to NM‐induced anaphylaxis but was not reflected in the allergy tests. Rare but life‐threatening drawbacks occur immediately after hemodialysis initiation.